Retatrutide Black Market Pulls 15 Pounds Into U.S. Ahead of 2027 Launch
Updated
Updated · The New York Times · Jun 18
Retatrutide Black Market Pulls 15 Pounds Into U.S. Ahead of 2027 Launch
1 articles · Updated · The New York Times · Jun 18
Summary
Fifteen pounds of unapproved retatrutide entered the United States from January through April 2026, according to an FDA-data analysis cited by the Partnership for Safe Medicines.
That flow reflects demand for Eli Lilly’s experimental obesity drug, which is not expected to reach the U.S. market before next year at the earliest.
Online sellers offer $99 vials marked "for research purposes only," while buyers use Reddit, Discord and WhatsApp to find Chinese suppliers, pool orders and arrange third-party testing.
Social media influencers and medical spas also promote the drug with coded terms such as "ratatouille" and "peps," helping a sizable illicit market operate despite advertising restrictions.
Experts say the volume could equal hundreds of thousands of doses, though some imports may have gone to legitimate researchers rather than consumers.
You can buy Retatrutide online, but are you injecting a weight-loss miracle or a chemical cocktail from China?
As the black market for a 'miracle' drug booms, is the FDA's approval process now dangerously outdated?
Black Market Retatrutide Surges 265%: Health Risks, Regulatory Gaps, and the Unapproved Weight-Loss Drug Crisis (June 2026)
Overview
As of June 2026, Retatrutide remains unapproved by the FDA, yet black market versions are widely available online and in clinics. These unauthorized products lack quality control, putting users at risk due to unknown purity and dosing. Public health data shows a sharp rise in poison center reports linked to unapproved Retatrutide, highlighting serious safety concerns. Side effects from these black market drugs are often more severe and unpredictable than those seen in clinical trials. The growing demand, fueled by limited legal access and social media hype, has created a significant public health challenge.